Precision NanoSystems products

Transformative medicines start with novel materials that can be costly or in limited supply. The Spark is ideal for screening novel genetic medicine formulations because it provides:

Genetic medicines have a wide design space that requires optimization to select a lead candidate. The Ignite is ideal for fine tuning process parameters and compositions for further scale up to the clinic.

The NanoAssemblr® Blaze allows rapid scaling of nanoparticle formulations for late pre-clinical development. The system can manufacture between 10 mL and 10 L of formulation which allows researchers to use the Blaze for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies.

GenVoy-ILM, an off-the-shelf Research Use Only lipid nanoparticle reagent, lowers the barriers to developing genetic medicines. GenVoy-ILM™ is an ionizable lipid mix that enables the rapid and easy production of RNA-loaded lipid nanoparticles (LNPs) using the NanoAssemblr®Platform.  GenVoy-ILM is the simplest way to get started with LNPs - the most advanced non-viral technology for delivering nucleic acids.

Rethink Cell Therapy with Lipid Nanoparticles. Lipid Nanoparticle (LNP) based technology enables researchers to establish a clinically relevant, scalable method for ex vivo gene delivery.

Lipid nanoparticle (LNP) based technology enables researchers to establish a clinically relevant, scalable method for ex vivo gene delivery.